TNF Pharmaceuticals, Inc. (TNFA)
USD 0.28
(7.26%)
USD 0.28
(7.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.98 Million | -12.27 Million | -19.51 Million | -11.92 Million | -3.07 Million | -8.51 Million |
| Net Income | -3.99 Million | -15.19 Million | -29.88 Million | -12.15 Million | -3.38 Million | -10.84 Million |
| Depreciation & Amortization | - | - | - | 29.45 Thousand | 74.06 Thousand | 234.48 Thousand |
| Deferred income taxes | - | - | - | - | - | 156.49 Thousand |
| Stock-based compensation | 3.04 Million | 695.19 Thousand | 15.03 Million | 2.86 Million | 3.57 Million | - |
| Change in working capital | 815.51 Thousand | 2.22 Million | -5.18 Million | 822.13 Thousand | -179.55 Thousand | 684.94 Thousand |
| Other non-cash items | -10.83 Million | -988.39 Thousand | 19.82 Million | -1.34 Million | 861.95 Thousand | 821.42 Thousand |
| Investing Cash Flow | 1.84 Million | 6.91 Million | 19.85 Million | -8.75 Million | -3.94 Million | -344.5 Thousand |
| Investments in PPE | 5.00 | - | - | - | - | -68.21 Thousand |
| Acquisitions | - | - | 1.38 Million | - | 6250.00 | - |
| Investment purchases | -13.45 Million | -4.83 Million | -13.4 Thousand | -9.87 Million | -6.7 Million | -6.58 Million |
| Sales/Maturities of investments | 15.3 Million | 11.75 Million | 18.48 Million | 2.31 Million | 2.85 Million | 6.31 Million |
| Other Investing Activities | 1.84 Million | 6.91 Million | 1.38 Million | -1.2 Million | -100 Thousand | - |
| Financing Cash Flow | 13.06 Million | 5.55 Million | 73.53 Thousand | 38.66 Million | 6.96 Million | 9.1 Million |
| Debt repayment | - | - | -73.53 Thousand | -2.69 Million | -1.92 Million | - |
| Dividends payments | -1.45 Million | - | - | - | - | - |
| Common Stock Repurchased | -89.63 Thousand | - | - | - | - | - |
| Common Stock Issuance | 14.68 Million | 5.55 Million | - | 38.66 Million | 6.96 Million | 9.1 Million |
| Other Financing Activities | -77.09 Thousand | 5.55 Million | 3.01 Million | 3.25 Million | 2.97 Million | - |
| Accounts receivables | - | - | - | 42.88 Thousand | 128.12 Thousand | 631.51 Thousand |
| Accounts payables | 1.04 Million | 1.68 Million | -4.26 Million | 733.53 Thousand | -443.73 Thousand | 188.46 Thousand |
| Inventory | - | - | - | 1262.00 | 14.28 Thousand | 83.31 Thousand |
| Other working capital | -227.47 Thousand | 542.47 Thousand | -912.89 Thousand | 44.46 Thousand | 121.77 Thousand | -218.34 Thousand |
| Cash at beginning of period | 749.09 Thousand | 555.96 Thousand | 18.61 Million | 517.44 Thousand | 181.75 Thousand | 438.43 Thousand |
| Cash at end of period | 2.68 Million | 749.09 Thousand | 555.96 Thousand | 18.61 Million | 517.44 Thousand | 181.75 Thousand |
| Capital Expenditure | 5.00 | - | - | - | - | -68.21 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.93 Million | 193.12 Thousand | -18.06 Million | 18.1 Million | 335.68 Thousand | -256.67 Thousand |
| Free Cash Flow | -12.98 Million | -12.27 Million | -19.51 Million | -11.92 Million | -3.07 Million | -8.58 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.56 Million | -9.8 Million | -3.99 Million | -2.36 Million | 4.04 Million | -4.16 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 8.91 Million | 488.1 Thousand | 3.04 Million | 1.61 Million | 385.14 Thousand | 1.02 Million |
| Change in working capital | 240.36 Thousand | 336.91 Thousand | 815.51 Thousand | 2.15 Million | 129.67 Thousand | 9635.00 |
| Other non-cash items | 5.9 Million | 7.4 Million | -10.83 Million | -3.4 Million | -7.2 Million | -549.1 Thousand |
| Investing Cash Flow | -11.02 Million | 732.02 Thousand | 1.84 Million | 5.93 Million | 3.36 Million | 3.82 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -12.52 Million | -18.3 Thousand | -13.45 Million | -115.83 Thousand | -139.05 Thousand | -174.85 Thousand |
| Sales/Maturities of investments | 1.5 Million | 750.33 Thousand | 15.3 Million | 6.05 Million | 3.5 Million | 4 Million |
| Other Investing Activities | -11.02 Thousand | 732.02 Thousand | 1.84 Million | 5.93 Million | 3.36 Million | 3.82 Million |
| Financing Cash Flow | 14 Million | -1.27 Million | 13.06 Million | -1.61 Million | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | -1.13 Million | -1.45 Million | -1.45 Million | - | - |
| Common Stock Repurchased | - | -73.47 Thousand | -89.63 Thousand | -89.63 Thousand | - | -14.68 Million |
| Common Stock Issuance | 14 Million | - | 14.68 Million | - | - | - |
| Other Financing Activities | 14 Thousand | -68.1 Thousand | -77.09 Thousand | -77.09 Thousand | - | 14.68 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 755.28 Thousand | 145.01 Thousand | 1.04 Million | 1.68 Million | -122.61 Thousand | 787.25 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -746.37 Thousand | 191.89 Thousand | -227.47 Thousand | 470.04 Thousand | 252.28 Thousand | -777.61 Thousand |
| Cash at beginning of period | 225.65 Thousand | 2.68 Million | 749.09 Thousand | 298.31 Thousand | 93.82 Thousand | 188.54 Thousand |
| Cash at end of period | 536.02 Thousand | 225.65 Thousand | 2.68 Million | 2.68 Million | 298.31 Thousand | 93.82 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 310.37 Thousand | -2.45 Million | 1.93 Million | 2.38 Million | 204.49 Thousand | -94.72 Thousand |
| Free Cash Flow | -2.66 Million | -1.91 Million | -12.98 Million | -1.93 Million | -3.15 Million | -3.91 Million |
LNR
474490
BVA
OGE
ASAI
0419